The use of a registry database in clinical trial design: Assessing the influence of entry criteria on statistical power and number of eligible patients

International Journal of Medical Informatics

Volumn 76, Issue 2-3, 2007, Pages 176-183

  Peelen, Linda ^a   Peek, Niels ^a   de Jonge, Evert ^a   Scheffer, Gert Jan ^b   de Keizer, Nicolette F ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical trial design; Registries; Selection criteria; Sepsis; Statistical power

Indexed keywords

CLINICAL TRIAL DESIGN; REGISTRIES; SELECTION CRITERIA; SEPSIS; STATISTICAL POWER;

ECONOMIC AND SOCIAL EFFECTS; HOSPITAL DATA PROCESSING; MEDICAL COMPUTING; PATIENT MONITORING; POPULATION STATISTICS;

DATABASE SYSTEMS;

ARTICLE; DATA BASE; DECISION MAKING; ECONOMIC ASPECT; HUMAN; MEDICAL INFORMATICS; MEDICAL INFORMATION; ORGANIZATION AND MANAGEMENT; PATIENT; PRIORITY JOURNAL; REGISTER; SEPSIS;

HUMANS; MODELS, STATISTICAL; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH DESIGN; SEPSIS;

EID: 33846813707     PISSN: 13865056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmedinf.2006.05.036     Document Type: Article

References (17)

1. Altman D.G., and Bland J.M. Absence of evidence is not evidence of absence. BMJ 311 (1995) 485
2. Rosner B. Fundamentals of Biostatistics. third ed. (1990), PWS-Kent, Boston
3. Connelly L.B. Balancing the number and size of sites: an economic approach to the optimal design of cluster samples. Control. Clin. Trials 24 (2003) 544-559
4. H. Reitsma, Registers in cardiovascular epidemiology. Ph.D. thesis, Faculty of Medicine, University of Amsterdam, 1999. Accessible through: http://dare.uva.nl/record/73725.
5. Friedman L.M., Furberg C.D., and DeMets D.L. Fundamentals of clinical trials. third ed. (1998), Springer Verlag, New York Chapter 3
6. Wheeler A.P., and Bernard G.R. Treating patients with severe sepsis. N. Engl. J. Med. 340 (1999) 207-214
7. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101 (1992) 1644-1655
8. 2, in patients with suspected sepsis and organ failure. Crit. Care Med. 31 (2003) 718-728
9. National Intensive Care Evaluation (NICE) foundation. Website: www.stichting-nice.nl (also in English, last visited June 11th, 2006).
10. Arts D.G.T., De Keizer N.F., and Scheffer G.J. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J. Am. Med. Inform. Assoc. 9 (2002) 600-611
11. Peelen L., De Keizer N.F., Peek N., Bosman R.J., Scheffer G.J., and De Jonge E. Influence of entry criteria on mortality risk and number of eligible patients in recent studies on severe sepsis. Crit. Care Med. 33 10 (2005) 2178-2183
12. Kiefer J. Optimum experimental designs. J. R. Statist. Soc. B 21 (1959) 272-304
13. Howes S., and Lanjouw P. Does sample design matter for poverty rate comparisons?. Rev. Income. Wealth 44 (1998) 99-109
14. Kerry S.M., and Bland J.M. Sample size in cluster randomisation. BMJ 316 (1998) 549
15. Rubin D.L., Gennari J.H., Srinivas S., et al. Tool support for authoring eligibility criteria for cancer trial. Proceedings of The AMIA Fall Symposium. Washington, DC (1999) 369-373
16. Modgil S., and Hammond P. Decision support for clinical trial design. Artif. Intell. Med. 27 (2003) 181-200
17. B. Efron, The jackknife, bootstrap and other resampling plans. CMBS-NSF Regional Conference Series in Applied Mathematics # 38. Society for Industrial and Applied Mathematics, 1982.